GlassScriptPhysician profile
Dena Patel
NPI 1881188951
$3,850.35
in general payments reported to CMS, 2019-2025
35 companies · $772 in 2025
The $772 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $908 · 2022: $601 · 2023: $453 · 2024: $1,117 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,341.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $834.14 | 2024-2025 | Intellis Adaptivestim, Interstim |
| Novo Nordisk INC | $618.47 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $342.29 | 2021-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $246.34 | 2021-2025 | |
| Pfizer INC. | $146.33 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.53 | 2021-2024 | Trintellix |
| Amarin Pharma, INC. | $137.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $136.16 | 2021-2023 | Spravato |
| Dexcom, INC. | $108.98 | 2022-2025 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $108.24 | 2024-2025 | Inspire |
| Supernus Pharmaceuticals, INC. | $105.20 | 2021-2023 | Qelbree |
| Abbott Laboratories | $92.20 | 2023-2025 | Freestyle Libre 3 |
| Amgen INC. | $90.08 | 2021-2025 | Repatha, Otezla |
| Corcept Therapeutics | $84.32 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $80.64 | 2023-2025 | Trelegy Ellipta, Shingrix, Menveo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $79.76 | 2021-2025 | Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $66.18 | 2021-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $61.16 | 2021-2023 | Belsomra, Steglatro |
| Eisai INC. | $49.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.78 | 2021-2022 | |
| Exact Sciences Corporation | $36.79 | 2023-2024 | Cologuard Collection Kit |
| Lundbeck LLC | $30.78 | 2025 | Rexulti |
| Corium, LLC | $23.60 | 2025 | Azstarys |
| Harmony Biosciences LLC | $23.18 | 2024 | |
| Dynavax Technologies Corporation | $20.27 | 2024 | Heplisav-B |
| Athena Bioscience, LLC | $18.75 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.29 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $16.29 | 2022 | |
| Nevro Corp. | $15.88 | 2023 | Senza |
| Arbor Pharmaceuticals, INC. | $14.37 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.89 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $13.80 | 2023 | |
| Currax Pharmaceuticals LLC | $13.79 | 2025 | Contrave |
| Acerus Pharmaceuticals Corporation | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.